A new television series called Mount Sinai Future You, which highlights innovation at Mount Sinai, is being broadcast on CUNY TV, the non-commercial educational-access cable channel run by The City University of New York.
Mount Sinai Future You takes viewers behind the scenes as doctors at Mount Sinai Health System leverage innovative science to change patients’ lives every day. The series highlights preventative care and treatment models that will lead to better health and longer lives.
New episodes of Mount Sinai Future You will run monthly, in the first week of each month, on Wednesdays at 9:30 pm, Thursdays at 6:30 am and 5 pm, and Saturdays at 11 am. They will cover newsworthy topics in medicine, as well as highlight new treatments, innovations, and preventive care for patients. The series is produced by Mount Sinai.
Mount Sinai Future You, Episode 3, features:
A 22-year-old man from Idaho with a rare facial tumor called a lymphangioma. Following two dozen unsuccessful surgeries, he sought treatment from Gregory Levitin, MD, Director of Vascular Birthmarks and Malformations at New York Eye and Ear Infirmary of Mount Sinai, and one of the only surgeons in the country with expertise resecting these types of tumors.
An interview with Paula Klein, MD, Medical Director of Breast Cancer Clinical Trials and Charles Shapiro, MD, Director of Translational Breast Cancer Research, on new technologies allowing breast cancer patients undergoing chemotherapy to keep their hair during treatment and the latest research allowing many early-stage breast cancer patients to avoid using chemotherapy.
David Stark, MD, Director of Lab 100, discusses the hybrid clinic-research lab that is leveraging data from physical fitness and cognitive tests to help doctors obtain a more comprehensive health assessment of their patients.
Sam Gandy, MD, PhD, Associate Director of Mount Sinai Alzheimer’s Disease Research Center, and Joel Dudley, PhD, Director of the Institute for Next Generation Healthcare, discover a link between strains of the herpes virus and Alzheimer’s disease.
Kevin Costa, PhD, Director of Cardiovascular Cell and Tissue Engineering, shares the latest research on stem cells that are engineered to create new heart cells.
Go to www.mountsinai.org/FutureYou for more information.
Mount Sinai Future You - Episode 3 alzheimer's disease medication | |
| 9 Likes | 9 Dislikes |
| 646 views views | 36K followers |
| Education | Upload TimePublished on 6 Jul 2018 |
